TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Olink Proteomics AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
120,338
|
132,797
|
122,009 |
| Financial expenses |
1,187
|
4,399
|
425 |
| Earnings before taxes |
-44,936
|
-8,116
|
412 |
| EBITDA |
-45,173
|
-1,348
|
2,192 |
| Total assets |
147,209
|
168,986
|
112,869 |
| Current assets |
68,110
|
96,168
|
81,662 |
| Current liabilities |
50,454
|
25,577
|
78,914 |
| Equity capital |
96,755
|
143,410
|
33,955 |
| - share capital |
4
|
5
|
4 |
| Employees (average) |
394
|
362
|
289 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
65.7%
|
84.9%
|
30.1% |
| Turnover per employee |
305
|
367
|
422 |
| Profit as a percentage of turnover |
-37.3%
|
-6.1%
|
0.3% |
| Return on assets (ROA) |
-29.7%
|
-2.2%
|
0.7% |
| Current ratio |
135.0%
|
376.0%
|
103.5% |
| Return on equity (ROE) |
-46.4%
|
-5.7%
|
1.2% |
| Change turnover |
-7,944
|
10,432
|
51,910 |
| Change turnover % |
-6%
|
9%
|
74% |
| Chg. No. of employees |
32
|
73
|
106 |
| Chg. No. of employees % |
9%
|
25%
|
58% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.